0001209191-20-058171.txt : 20201112 0001209191-20-058171.hdr.sgml : 20201112 20201112200009 ACCESSION NUMBER: 0001209191-20-058171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201102 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiang Kyle CENTRAL INDEX KEY: 0001831341 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 201308721 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-02 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001831341 Chiang Kyle C/O LOGICBIO THERAPEUTICS, INC. 65 HAYDEN AVE, FLOOR 2 LEXINGTON MA 02421 0 1 0 0 Chief Operating Officer Stock Option (right to buy) 5.65 2020-11-02 4 A 0 85000 0.00 A 2030-11-02 Common Stock 85000 85000 D 25% vests on 11/02/2021 and the remainder vests in equal monthly installments over the next 36 months. /s/ Jonathan Quick, as Attorney-in-Fact 2020-11-12